NASDAQ:DYN | Free Cash Flow | Dyne Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$144.92M$221,000.00-$145.14M
2025-12-31-$111.83M$484,000.00-$112.32M
2025-03-31-$105.89M$981,000.00-$106.87M
2024-12-31-$84.34M$1.08M-$85.41M
2024-03-31-$78.54M$191,000.00-$78.73M
2023-12-31-$35.01M$82,000.00-$35.09M
2023-03-31-$46.91M$230,000.00-$47.14M
2022-12-31-$29.19M$519,000.00-$29.71M
2022-03-31-$50.74M$1.4M-$52.14M
2021-12-31-$28.07M$1.99M-$30.06M
2021-03-31-$18.39M$9,000.00-$18.4M
2020-12-31-$20.04M$723,000.00-$20.76M
2020-03-31-$7.29M$211,000.00-$7.5M
2019-12-31-$4.01M$737,000.00-$4.75M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$403.21M$1.92M-$405.13M
2024-12-31-$292.37M$2.38M-$294.75M
2023-12-31-$188.16M$729,000.00-$188.89M
2022-12-31-$153.65M$3.07M-$156.71M
2021-12-31-$119.56M$3.62M-$123.18M
2020-12-31-$46.51M$1.16M-$47.67M
2019-12-31-$11.83M$1.65M-$13.48M